23
Participants
Start Date
March 20, 2017
Primary Completion Date
July 7, 2025
Study Completion Date
July 7, 2025
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Procedure: single intravenous infusion of JSP191 antibody
Memorial Sloan Kettering Cancer Center, New York
Children's National Medical Center, Washington D.C.
National Institutes of Health Clinical Center, Bethesda
Children's Healthcare of Atlanta, Atlanta
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Minnesota, Minneapolis
UCLA Mattel Children's Hospital, Los Angeles
UCSF Benioff's Children's Hospital, San Francisco
Lucile Packard Children's Hospital, Palo Alto
Lead Sponsor
Jasper Therapeutics, Inc.
INDUSTRY